标题
COVID-19 infection: an overview on cytokine storm and related interventions
作者
关键词
-
出版物
Virology Journal
Volume 19, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-05-26
DOI
10.1186/s12985-022-01814-1
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Interleukin 1α: a comprehensive review on the role of IL-1α in the pathogenesis and targeted treatment of autoimmune and inflammatory diseases
- (2021) Giulio Cavalli et al. AUTOIMMUNITY REVIEWS
- COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection
- (2021) Stephany Beyerstedt et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Efficacy of canakinumab in mild or severe COVID‐19 pneumonia
- (2021) Falasca Katia et al. Immunity Inflammation and Disease
- Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) François-Xavier Lescure et al. Lancet Respiratory Medicine
- The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
- (2021) Dounia Darif et al. MICROBIAL PATHOGENESIS
- Therapeutic use of specific tumour necrosis factor inhibitors in inflammatory diseases including COVID-19
- (2021) Serena Patel et al. BIOMEDICINE & PHARMACOTHERAPY
- Therapeutic targeting of IL-6 trans-signaling
- (2021) Stefan Rose-John CYTOKINE
- Interleukin‐17—A multifaceted cytokine in viral infections
- (2021) Utkarsha Sahu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China
- (2020) Dawei Wang et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID‐19) implicate special control measures
- (2020) Yixuan Wang et al. JOURNAL OF MEDICAL VIROLOGY
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- ICU-acquired weakness, diaphragm dysfunction and long-term outcomes of critically ill patients
- (2020) Clément Saccheri et al. Annals of Intensive Care
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Pathological findings of COVID-19 associated with acute respiratory distress syndrome
- (2020) Zhe Xu et al. Lancet Respiratory Medicine
- COVID-19 Autopsies, Oklahoma, USA
- (2020) Lisa M Barton et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms
- (2020) Federica Raucci et al. AUTOIMMUNITY REVIEWS
- Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
- (2020) Paola Toniati et al. AUTOIMMUNITY REVIEWS
- COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
- (2020) Serena Colafrancesco et al. AUTOIMMUNITY REVIEWS
- Interleukin-1 and the Inflammasome as Therapeutic Targets in Cardiovascular Disease
- (2020) Antonio Abbate et al. CIRCULATION RESEARCH
- Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis
- (2020) Gaurav Aggarwal et al. CURRENT PROBLEMS IN CARDIOLOGY
- Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
- (2020) Corrado Campochiaro et al. European Journal of Internal Medicine
- The pivotal link between ACE2 deficiency and SARS-CoV-2 infection
- (2020) Paolo Verdecchia et al. European Journal of Internal Medicine
- COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
- (2020) Toshio Hirano et al. IMMUNITY
- Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis
- (2020) Jieyun Zhu et al. JOURNAL OF MEDICAL VIROLOGY
- COVID‐19 pneumonia treated with Sarilumab: a clinical series of eight patients
- (2020) Maurizio Benucci et al. JOURNAL OF MEDICAL VIROLOGY
- TH17 responses in cytokine storm of COVID-19: An emerging target of JAK2 inhibitor Fedratinib
- (2020) Dandan Wu et al. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed
- (2020) Marc Feldmann et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- ADAM17 inhibition may exert a protective effect on COVID-19
- (2020) Vanesa Palau et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effective treatment of severe COVID-19 patients with tocilizumab
- (2020) Xiaoling Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review
- (2020) Sasmita Poudel Adhikari et al. Infectious Diseases of Poverty
- Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
- (2020) Bo Diao et al. Frontiers in Immunology
- Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection
- (2020) Xin Zou et al. Frontiers of Medicine
- Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury
- (2020) Yingxia Liu et al. National Science Review
- The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease
- (2020) Dennis McGonagle et al. AUTOIMMUNITY REVIEWS
- Potential role of IL‐17 blocking agents in the treatment of severe COVID‐19?
- (2020) Vedrana Bulat et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized COVID-19 Patients
- (2020) Christina C. Price et al. CHEST
- Cytokine release syndrome and the prospects for immunotherapy with COVID-19. Part 2: The role of interleukin 1
- (2020) Leonard H. Calabrese et al. CLEVELAND CLINIC JOURNAL OF MEDICINE
- The cytokine storm of COVID-19: a spotlight on prevention and protection
- (2020) Lucie Pearce et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: A retrospective case-control survival analysis of 128 patients
- (2020) Lorenzo M. Canziani et al. JOURNAL OF AUTOIMMUNITY
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- May IL-17 have a role in COVID-19 infection?
- (2020) Matteo Megna et al. MEDICAL HYPOTHESES
- Neurological Involvement in COVID-19 and Potential Mechanisms: A Review
- (2020) Ghazal Aghagoli et al. Neurocritical Care
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Preliminary predictive criteria for COVID-19 cytokine storm
- (2020) Roberto Caricchio et al. ANNALS OF THE RHEUMATIC DISEASES
- Lymphopenia during the COVID-19 infection: What it shows and what can be learned
- (2020) Soheil Tavakolpour et al. IMMUNOLOGY LETTERS
- Efficacy of Tocilizumab in Patients Hospitalized with Covid-19
- (2020) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin‐6 in Covid‐19: A systematic review and meta‐analysis
- (2020) Eric A. Coomes et al. REVIEWS IN MEDICAL VIROLOGY
- Cytokines and COVID-19: friends or foes?
- (2020) Mohsen Rokni et al. Human Vaccines & Immunotherapeutics
- Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
- (2020) Antonella Fara et al. Open Biology
- Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia
- (2020) Olivier Hermine et al. JAMA Internal Medicine
- Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
- (2020) Carlo Salvarani et al. JAMA Internal Medicine
- Inflammatory Cytokine: IL-17A Signaling Pathway in Patients Present with COVID-19 and Current Treatment Strategy
- (2020) Tewodros Shibabaw Journal of Inflammation Research
- A comprehensive review on sarilumab in COVID-19
- (2020) Sajad Khiali et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Canakinumab as treatment for COVID-19-related pneumonia: a prospective case-control study
- (2020) Daniele Generali et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Pathophysiology of COVID-19-associated acute respiratory distress syndrome – Authors' reply
- (2020) Giacomo Grasselli et al. Lancet Respiratory Medicine
- Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: Results of a prospective, open-label, interventional study
- (2020) A. Balkhair et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- The Coagulation and Immune Systems Are Directly Linked through the Activation of Interleukin-1α by Thrombin
- (2019) Laura C. Burzynski et al. IMMUNITY
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- The protective and pathogenic roles of IL-17 in viral infections: friend or foe?
- (2019) Wen-Tao Ma et al. Open Biology
- ADAM17 Activity and IL-6 Trans-Signaling in Inflammation and Cancer
- (2019) Schumacher et al. Cancers
- Simultaneous presence of hypercoagulation and increased clot lysis time due to IL-1β, IL-6 and IL-8
- (2018) Janette Bester et al. CYTOKINE
- MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile
- (2018) Waleed H. Mahallawi et al. CYTOKINE
- Anakinra for the treatment of rheumatoid arthritis: a safety evaluation
- (2018) Julio Ramírez et al. Expert Opinion On Drug Safety
- A review of sarilumab for the treatment of rheumatoid arthritis
- (2018) Eun Bong Lee Immunotherapy
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- IL-6: a cytokine at the crossroads of autoimmunity
- (2018) Britta E Jones et al. CURRENT OPINION IN IMMUNOLOGY
- The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders
- (2018) Kuo-Chen Wu et al. JOURNAL OF FOOD AND DRUG ANALYSIS
- Overview of the IL-1 family in innate inflammation and acquired immunity
- (2017) Charles A. Dinarello IMMUNOLOGICAL REVIEWS
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology
- (2017) Rudragouda Channappanavar et al. Seminars in Immunopathology
- Comparative efficacy and tolerability of sarilumab 150 and 200 mg in patients with active rheumatoid arthritis
- (2017) S.-C. Bae et al. ZEITSCHRIFT FUR RHEUMATOLOGIE
- Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
- (2017) Maria Gabriella Raimondo et al. Drug Design Development and Therapy
- Trans-presentation of IL-6 by dendritic cells is required for the priming of pathogenic TH17 cells
- (2016) Sylvia Heink et al. NATURE IMMUNOLOGY
- FDA Approval: Siltuximab for the Treatment of Patients with Multicentric Castleman Disease
- (2015) A. Deisseroth et al. CLINICAL CANCER RESEARCH
- Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
- (2015) Marine Lacroix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The molecular mode of action and species specificity of canakinumab, a human monoclonal antibody neutralizing IL-1β
- (2015) Jean-Michel Rondeau et al. mAbs
- TNF biology, pathogenic mechanisms and emerging therapeutic strategies
- (2015) George D. Kalliolias et al. Nature Reviews Rheumatology
- Clinical Development of Siltuximab
- (2015) Christine C. Davis et al. Current Oncology Reports
- Interleukin-6 and its receptors: A highly regulated and dynamic system
- (2014) Janina Wolf et al. CYTOKINE
- T Cell Responses to Whole SARS Coronavirus in Humans
- (2014) C. K.-f. Li et al. JOURNAL OF IMMUNOLOGY
- Interleukin-6 (IL-6) and IL-17 Synergistically Promote Viral Persistence by Inhibiting Cellular Apoptosis and Cytotoxic T Cell Function
- (2014) W. Hou et al. JOURNAL OF VIROLOGY
- RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway
- (2014) Xiaqiong Wang et al. NATURE IMMUNOLOGY
- Intracellular Interleukin-1 Receptor 2 Binding Prevents Cleavage and Activity of Interleukin-1α, Controlling Necrosis-Induced Sterile Inflammation
- (2013) Yue Zheng et al. IMMUNITY
- IL-17 cytokines in immunity and inflammation
- (2013) Wei Jin et al. Emerging Microbes & Infections
- Tocilizumab – A novel therapy for non-organ-specific autoimmune diseases
- (2012) Lisa Kaly et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer
- (2011) Markus F. Neurath et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Anti-interleukin-6 receptor antibody, tocilizumab, for the treatment of autoimmune diseases
- (2011) Toshio Tanaka et al. FEBS LETTERS
- IL-6: Regulator of Treg/Th17 balance
- (2010) Akihiro Kimura et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Immunological and Inflammatory Functions of the Interleukin-1 Family
- (2009) Charles A. Dinarello Annual Review of Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now